Corrado Panno

Stay Ahead with Neopharm Adapting to the BIOSECURE Act? Neopharm provides tailored CRO services and GMP compliance in North America to keep your biopharma operations secure and compliant. Stay ahead with our expert solutions. Learn more: https://hubs.li/Q02Sn3290 Sponsored by Neopharm Labs #Biopharma #Pharmaceuticals #Compliance #BIOSECUREAct #R&D #RegulatoryExcellence #SupplyChainSecurity #Neopharm

8

Pharma companies have many market access tasks to complete in the year leading up to launch. MMIT’s Ryan Witherington and Carolyn Zele share six key areas to focus on: https://ow.ly/sXkh50TyVth

7

Using MMIT data, researchers found that Part D plans are more likely than employer-sponsored plans to prefer reference biologics to biosimilars. https://ow.ly/MGWi30sFTEf This will change with the full implementation of the IRA. Learn more in this Q&A with Harvard researcher Luca Maini.

5

Many innovative ideas can become obscured when communicated, which was a significant challenge for Patient Blood Management #PBM as it was introduced to benefit those suffering from #anemia, in hopes of enabling surgery without the use of donated blood upon leaving the ER (Emergency Room). The PBM educational approach supports bloodless surgical procedures. To reduce this obscurity, we are simplifying the message and increasing awareness, benefiting #researchers, manufacturers, and healthcare practitioners. Most importantly, we are enhancing the patient experience and raising public awareness. We are confident that many global organizations, healthcare providers, and blood management surgical equipment manufacturers will support our efforts as we continue to be pioneers in building a bridge of engagement for public access, which will benefit this field of medicine. Remember our medical icons, just in case one day you need direction to the OR. #Bloodlines #BBTS #Blood #SABM

5

Our tailored solutions in commercial capability building empower BioPharma companies to enhance their sales, marketing, and distribution strategies. From training programs to performance analytics, we equip your team with the skills and tools they need to drive growth and maximize impact. Elevate your commercial capabilities with Boston Biopharma today. #BiotechPharma #Biotech #pharmaceutical #pharma #healthcare #medicine #BostonBioPharmaConsultants #marketing

1

Harness the power of social media and influencer strategy with Boston BioPharma Consultants. Our tailored services help BioPharma companies build a strong online presence, engage with stakeholders, and drive brand awareness. Let us elevate your social media game and connect you with influential voices in the industry. Contact us today! #BiotechPharma #Biotech #pharmaceutical #pharma #healthcare #medicine #BostonBioPharmaConsultants #marketing

1

Breast cancer research shows no signs of slowing. We dug into the data from Citeline’s Trialtrove to give you key insights from active #breastcancer clinical trials. https://hubs.ly/Q02SsbPn0 #oncology #clinicaltrials #drugdevelopment

28

1 Comment

🛑 Have you registered for our KOL webinar tomorrow? If not, please do here: https://lnkd.in/ddhStUr5. Join us at 12:00 PM ET tomorrow for our online KOL and investor webinar titled "Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications." Yale Jen, Ph.D., Senior Managing Director of Equity Research at Laidlaw Capital Markets, will moderate the event, which will also feature key participation from Dr. Michael Cline, Medical Director of the Cleveland Clinic's gastroparesis clinic. 🔍 Key Highlights: Expert Insights: Dr. Cline will share his expertise on the rising incidence of gastroparesis linked to GLP-1 medications and the patient experience with GIMOTI®. In-Depth Discussion: Explore current data on healthcare resource utilization related to GIMOTI® and learn how it's shaping the future of gastroparesis treatment. Got questions? Please email [email protected] to have them answered during the webinar. #EvokePharma #Gastroparesis #FightDGP #GIMOTI

9

See how HCP Message Monitor helped a pharma manufacturer understand message effectiveness and ensure recall in our latest case study. https://ow.ly/UmC750TQitM

7

Patient for Life™ turns every exome into a living test. Ambry continues to search for answers for patients and proactively issues updated reports as new gene-disease associations are validated. Learn more about how our commitment to patients makes a difference: https://hubs.ly/Q02F23yS0 #PatientforLife #exome #raredisease #neurology #VUS

26

Molecular diagnostic companies with rich patient assay data are in a unique position to leverage this data to address their marketplace challenges. What are the considerations organizations need to consider to create an effective strategy for utilzing their omics real-world data (oRWD)? Read more: https://hubs.ly/Q031NSvc0

2

Supercharge Your Sales Force with Personalized Engagement ⚡️ Life sciences sales are all about building strong relationships. Close-up CRM empowers your reps with the tools they need to personalize every interaction. The result? Increased engagement and impactful results. Ready to take your sales game to the next level? Visit us at www.closeupcrm.com to learn more. #LifeSciences #SalesForceAutomation #PharmaSales #CRM #OmnichannelMarketing #AI #SalesEngagement #PersonalizedSelling #SalesTech

16

On this #MedicalMonday, we are proud to share that our Healthcare Industry Manager, Derek Gagnon, is now collaborating with and contributing to the important mission of the BioPhorum Supply Resilience Leadership Team! The team brings together supplier and manufacturer supply chain leaders to deal with current issues and build a future-focused approach to the industry. Built around a strategic framework, there are 5 strategic goals to tackle challenges within the industry with BioPhorum. The strategic goals are: 1. To lead by industry insights on emerging patterns and trends. 2. Provide a safe and adaptable supply chain which works in harmony with biomanufacturing. 3. Create a fully digitized supply chain that supports commerce, quality, and data sharing. 4. Develop strong, open relationships across the supply chain for better quality and less risk. 5. Build a sustainable supply chain that does no harm to the planet, person, or product.

20

Register now: https://loom.ly/V7hvN_g Join experts from AssistRx and MMIT (Managed Markets Insight & Technology) on Dec. 3 at 1 p.m. ET to discover the strategies life sciences organizations can use to alleviate copay program disruptions in 2025. During the webinar, we’ll detail how the perfect blend of tech and talent can help address recent payer activity, including new payer utilization management strategies and the changing copay accumulator and maximizer landscape. Can’t make it live? Request a recording when you sign up to view on your schedule. #InformedAccess #ImprovedOutcomes

15

BioCentury Inc. recently spoke to our CEO, John Montana, for an ‘Emerging company profile’ article on Calluna Pharma – featuring exclusive insights about the story behind the merger, Calluna’s mission, and therapeutic pipeline. Sharing an update about Calluna’s lead clinical program, CAL101, John mentioned that safety and pharmacokinetic data are expected this summer, after which the program will enter a Phase II trial looking at fibrotic and inflammatory / autoimmune indications. Find a link to the full article in the comments, below. #Biotech #Biopharma #Immunology #Clinical #Innovation

31

1 Comment